Pilot Projects 2015-2016
Jose Aleman, MD, PhD
Breslow Laboratory
Mechanisms of accelerated atherosclerosis in brown adipose tissue expansion
Tali Czarnowicki, MD
Krueger Laboratory
Phenotype, regulation and development of the immune system in adult atopic dermatitis patients
Oyebisi Jegede, MBBS, PhD
Rice Laboratory
Effects of chronic viral infection on immune response to Zoster vaccination
Gadi Lalazar, MD
Simon Laboratory
Phosphoproteomics of Fibrolamellar Hepatocellular Carcinoma
Avi Levin, MD
Steller Laboratory
Colon cancer-associated proteasomal assembly is a potential novel therapeutic target
Isaac Marin-Valencia
Gleeson Laboratory
Expanding diagnostic and therapeutic approaches for inherited brain metabolic disorders by exome analysis
Claudio Alarcon
Tavazoie Laboratory
Identifying factors that regulate the cross-talk between metastatic pancreatic cells and the immune system
Ursula Andreo, PhD
Rice Laboratory
The impact of metabolic syndrome on the antiviral immune response
Ype de Jong, MD, PhD
Rice Laboratory
Programmed bacteria to coordinately deliver antitumor therapeutics in hepatocellular carcinoma xenografts
Benjamin Farber, MD
Simon Laboratory
Using Non-coding RNAs as a Diagnostic tool in Fibrolamellar Hepatocellular Carcinoma
Paul Muller
Mucida Laboratory
ESTABLISHMENT OF AN ENTERIC NEURON TRANSCRIPTOME FOR PROBING OF NEUROIMMUNE INTERACTIONS
Lily Nguyen, MS
Cohen Laboratory
The role of adipose tissue in bariatric surgery
Virginia Pedicord
Hang Laboratory
Identifying beneficial gut bacteria mechanisms for the rational design of probiotics against intestinal infections
Kareem Rumah
Fischetti Lab
Identification of Clostridium perfringens enterotoxin as a novel candidate trigger for Sudden Infant Death Syndrome
Sameer Sharma
Steller Laboratory
“COCOON” – A Novel Intestinal Protective Agent
Jeanne Walker, MSN,NP-C
Rockefeller University Center for Clinical and Translational Science
JWA-0786 Pilot Study: The effects of trans-resveratrol (RSV) on insulin resistance, inflammation and the metabolic syndrome: A placebo controlled double-blind study.
Ethan Weinberg, MD
Tavazoie Laboratory
Phosphoenolpyruvate carboxykinase 1 (PCK1) is a potential therapeutic target for metastatic colorectal cancer liver colonization
Yuehyi Gloria Wu
Tavazoie Laboratory
Identifying and Characterizing Metastasis Regulators as Novel Therapeutic Targets for the Treatment of Pancreatic Adenocarcinoma
